Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
letter
. 1981 Oct;12(4):579–581. doi: 10.1111/j.1365-2125.1981.tb01268.x

Long-term low dose haloperidol treatment in rheumatoid patients: effects on serum sulphydryl levels, technetium index, ESR, and clinical response.

M G Grimaldi
PMCID: PMC1401902  PMID: 7295491

Full text

PDF
579

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boullin D. J., Glenton P. A. Characterization of receptors mediating 5-hydroxytryptamine- and catecholamine-induced platelet aggregation, assessed by the actions of alpha- and beta-blockers, butyrophenones, 5-HT antagonists and chlorpromazine. Br J Pharmacol. 1978 Apr;62(4):537–542. doi: 10.1111/j.1476-5381.1978.tb07758.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boullin D. J., Molyneux D., Roach B. The binding of haloperidol to human blood platelets and interactions with 5-hydroxytryptamine and dopamine. Br J Pharmacol. 1978 Jul;63(3):561–566. doi: 10.1111/j.1476-5381.1978.tb07812.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Crawford N. Some observations on the blood serotonin levels in rheumatoid arthritis with a study of platelet serotonin absorption. Clin Chim Acta. 1969 Jan;23(1):139–146. doi: 10.1016/0009-8981(69)90020-5. [DOI] [PubMed] [Google Scholar]
  4. ELLMAN G. L. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959 May;82(1):70–77. doi: 10.1016/0003-9861(59)90090-6. [DOI] [PubMed] [Google Scholar]
  5. Evans P. H. Serum sulphydryl changes in rheumatoid coalworkers' pneumoconiosis patients treated with D-penicillamine. Proc R Soc Med. 1977;70 (Suppl 3):95–97. doi: 10.1177/00359157770700S330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Grimaldi M. G. Serum sulfhydryl levels in rheumatoid patients treated with haloperidol. Scand J Rheumatol. 1980;9(4):225–228. doi: 10.3109/03009748009112352. [DOI] [PubMed] [Google Scholar]
  7. Grimaldi M. G. Serum sulphydryl concentrations and antirheumatic drugs in rheumatoid patients. J Pharm Pharmacol. 1980 Dec;32(12):876–876. doi: 10.1111/j.2042-7158.1980.tb13103.x. [DOI] [PubMed] [Google Scholar]
  8. Haataja M., Nissilä M., Ruutsalo H. M. Serum sulfhydryl levels in rheumatoid patients treated with gold thiomalate and penicillamine. Scand J Rheumatol. 1978;7(4):212–214. doi: 10.3109/03009747809095657. [DOI] [PubMed] [Google Scholar]
  9. Hall N. C., Gillan A. H. Effects of antirheumatic drugs on protein sulphydryl reactivity of human serum. J Pharm Pharmacol. 1979 Oct;31(10):676–680. doi: 10.1111/j.2042-7158.1979.tb13627.x. [DOI] [PubMed] [Google Scholar]
  10. Huskisson E. C., Scott J., Balme H. W. Objective measurement of rheumatoid arthritis using technetium index. Ann Rheum Dis. 1976 Feb;35(1):81–82. doi: 10.1136/ard.35.1.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pickup M. E., Dixon J. S., Bird H. A. On the effects of antirheumatic drugs on protein sulphydryl reactivity in human serum. J Pharm Pharmacol. 1980 Apr;32(4):301–302. doi: 10.1111/j.2042-7158.1980.tb12920.x. [DOI] [PubMed] [Google Scholar]
  12. Sinha Y. N., Selby F. W., Lewis U. J., VanderLaan W. P. A homologous radioimmunoassay for human prolactin. J Clin Endocrinol Metab. 1973 Mar;36(3):509–516. doi: 10.1210/jcem-36-3-509. [DOI] [PubMed] [Google Scholar]
  13. Yeatts R. P., Turner R., Collins R., Kaufmann J., Mashburn H. SOluble and insoluble immune complex-platelet interactions in rheumatoid inflammation. Ann Rheum Dis. 1978 Oct;37(5):421–427. doi: 10.1136/ard.37.5.421. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES